Blue Cross Blue Shield of Texas partners with Metamark Genetics to provide urologic cancer care
Blue Cross Blue Shield of Texas members now have access to urological care under a new agreement between the insurer and Metamark Genetics.
Metamark, based in Cambridge, Mass., provides diagnostic and prognostic information to help make treatment decisions for patients suffering from urological cancer. BCBS of Texas and Metamark announced the partnership yesterday in a statement.
The partnership comes at a time when Metamark is establishing connections with other Blue Cross and Blue Shield insurance plans and PPO networks across the country.
After acquiring Health Tronics Laboratory Solutions in 2013, Metamark became a leading provider for urology pathology, the company said.
"Metamark is delighted to be recognized as an in-network provider with Blue Cross and Blue Shield of Texas. Our continued momentum with payers across the U.S. reflects the substantial value our comprehensive suite of products and services provides to patients, physicians and insurers," said Jerry Williamson, president and CEO of Metamark, in a statement. "We maintain our strong commitment to improve the care of patients with urologic cancer by expanding access to vital, decision-making information throughout the complete diagnostic and therapeutic care journey."
Senior Writer
As a Senior Writer for TriMed Media Group, Katherine primarily focuses on producing news stories, Q&As and features for Cardiovascular Business. She reports on several facets of the cardiology industry, including emerging technology, new clinical trials and findings, and quality initiatives among providers. She is based out of TriMed's Chicago office and holds a bachelor's degree in journalism from Columbia College Chicago. Her work has appeared in Modern Healthcare, Crain's Chicago Business and The Detroit News. She joined TriMed in 2016.